The immediate-early (IE) genes of herpes simplex virus (HSV) have regulatory and immunomodulatory functions (Roizman & Sears, 1990 ; York et al., 1994) . Mutants in the IE gene ICP0 grow inefficiently and are reactivation-impaired (Cai & Schaffer, 1992 ; Cai et al., 1993 ; Clements & Stow, 1989 ; Leib et al., 1989 b) . ICP0 is a nuclear phosphoprotein which transactivates viral promoters at the transcriptional level (Cai & Schaffer, 1989 ; Everett, 1984 Everett, , 1989 Gelman & Silverstein, 1985 ; Jordan & Schaffer, 1997 ; O'Hare & Hayward, 1985 ; Perry et al., 1986 ; Samaniego et al., 1997 ; Weber & Wigdahl, 1992) and transactivation activity is required for reactivation (Cai et al., 1993) . The interaction of ICP0 with viral (Mullen et al., 1994 ; Yao & Schaffer, 1994 ; Zhu et al., 1994) and cellular proteins (Everett et al., 1997) indicates the complex regulation of its activity.
Viral and non-viral factors regulate ICP0 gene expression. Virion protein VP16 forms a complex with cellular factors Oct-1 and HCF, and upregulates IE gene transcription (Kristie & Roizman, 1987 ; McKnight et al., 1987) . Sp1 also upregulates the expression of IE genes (Jones & Tjian, 1985) . A CAATenhancer binding protein and a factor termed F2 bind overlapping sites from k89 to k74 and activate ICP0 expression (O'Rourke & O'Hare, 1993) . Also, sequences from k550 to k129 are required to induce ICP0 expression following release of cells from growth-arrest (Ralph et al., 1994) . ICP4 has been shown to repress ICP0 transcription (Faber & Wilcox, 1986) , although viruses mutated at ICP4-binding sites are not altered for growth in culture (Everett & Orr, 1991 ; Lium et al., 1996) . Also, octamer binding proteins can repress IE transcription by competing with Oct-1 for binding to octamer or octamer\TAATGARAT elements (Kemp et al., 1990 ; Lillycrop et al., 1994) . Indeed, TAATGARATs may both positively and negatively regulate IE promoters (Douville et al., 1995) . Finally, a cAMP-response element (CRE) has been described in the ICP0 promoter (Wheatley et al., 1992) , an intriguing finding given that cAMP accelerates reactivation (Bloom et al., 1994 ; Leib et al., 1991) .
The deletion mutant ∆Tfi, which is deleted from k420 to k70 of ICP0, exhibits reduced virulence but unaltered reactivation in mice (Davido & Leib, 1996) . This deletion in the ICP0 promoter removes the Sp1, NF-κB, C\EBP, F2 and four TAATGARAT sites, implying that other cis-elements upregulate ICP0 during reactivation. The purpose of this study was therefore to examine the roles of these other elements in ICP0 gene expression.
Baby hamster kidney (BHK), NB41A3 (murine neuroblastoma) and PC12 (rat pheochromocytoma) cells were obtained from and propagated as described by the ATCC. L7 Vero cells (Samaniego et al., 1997) , which express ICP0, were obtained from Neal DeLuca (University of Pittsburgh). The HSV-1 ICP0 null mutant, dlx3.1, was propagated as described previously (Sacks & Schaffer, 1987) and titred on L7 cells.
ICP0 promoter fragments from SacI (k800) to NcoI (j150) of pSP0 and pSP0T (Davido & Leib, 1996) were cloned into pGL3-Basic (Promega) to create pGL3jSP0 and pGL3jSP0T , TG (5h TAATGARAT 3h) and NF (NF-κB-like binding site, 5h GGGCTTCCC 3h). Below, selected restriction enzyme sites are shown (not to scale) at the following locations relative to the transcriptional start site : SacI (k809), StuI (k562), BstXI (k420), TfiI (k70), DrdI (k1) and NcoI (j150). Displayed beneath the restriction enzyme sites are the deletions and point mutations that were generated and cloned into pGL3-Basic (Promega). (b) Site-directed mutations generated at the ICP4/putative CRE (∆CRE), Sp1 (∆Sp1) and TATA box (∆TATA) DNA binding sites in the context of pGL3-95. (Davido & Leib, 1996) . SacI sites were introduced by sitedirected mutagenesis (SDM ; Kunkel, 1985) , digested with SacI and religated to create the mutants from k37 to k422 (Fig.  1 a) . pGL3-∆Drd was created as follows. pSP0T was digested with DrdI, blunt-ended and digested with XhoI to isolate a 1n1 kb fragment. Second, pSP0T was digested with BstXI, blunt-ended and digested with XhoI to isolate a 3n8 kb fragment. These two fragments were ligated to delete the promoter from k420 to k1. The ICP4\putative cAMP site, Sp1 DNA binding site and the TATA box were mutated by SDM as indicated (Fig. 1 b) . The promoter was amplified with 15 cycles of PCR with Klentaq (Wayne Barnes, Washington University) with primers 5h GCAGATCTAggctccatgggggtcgta 3h and 5h TTAAGAGctcccctgggacgcgcggcc 3h. PCR products were digested with SacI and NcoI, isolated and ligated into pGL3-95. Constructs were confirmed with the fmol DNA Sequencing System (Promega). p36pGL3 (prolactin TATA box) and pCRF-532L∆2S (corticotrophin-releasing factor promoter) plasmids were obtained from Stuart Adler (Washington University) as negative and positive controls respectively for cAMP-inducibility (Scatena & Adler, 1996) . The RSV promoter expressing the protein kinase A (PKA) catalytic subunit was obtained from Richard Maurer (University of Iowa) (Maurer, 1989) . pHCMV-MP1-lacZ was provided by Paul Olivo (Washington University) to control for transfection efficiency.
Transfections were performed as described (Chen & Okyama, 1987) . 2i10& NB41A3 cells, 4i10& PC12 cells and 1i10& BHK cells were seeded into six-well plates 24 h prior to transfection. NB41A3 and BHK cells were transfected with 3 µg DNA, PC12 cells were transfected with 6 µg DNA, and all cells with 0n5 µg pHCMV-MP1-lacZ DNA. NB41A3 or PC12 cells were treated with 500 µM 8-bromo-cAMP (Sigma) for 24 h, or BHK cells were infected with dlx3.1 for 6 h. Luciferase and β-galactosidase activities were assayed as described (Brasier et al., 1989 ; Rouet et al., 1992) .
ICP0 promoter activity decreased as the deletions became greater relative to the wild-type (k800 to j150) promoter (Fig. 2) . The largest reductions were 8-fold in NB41A3 (Fig.  2 a) , 45-fold in PC12 (Fig. 2 b) and 13-fold in BHK (Fig. 2 c) following deletion from k95 to k37, which contains Sp1, ICP4\putative CRE, F2 and C\EBP sites. Thus, in both neuronal and non-neuronal cells, this region is important for constitutive activity. Of interest, in both BHK (Fig. 2 c) and NB41A3 (data not shown) cells, the activity of the large deletion pGL3-∆Drd was equivalent or higher than that of pGL3-95. In PC12 cells there was a consistent 6-fold reduction in basal activity upon addition of k95 to k422 (Fig. 2 b) . It is not known whether this repression represents binding by a novel repressor, or recognition of octamer\TAATGARAT DNA motifs by a neuron-specific octamer binding repressor (Lillycrop et al., 1994) .
The ICP0 promoter has a CRE at k62 to k70 relative to the transcriptional start site (Wheatley et al., 1992) . This suggests that cAMP may activate ICP0 expression, thereby facilitating reactivation. In this study, however, none of the ICP0 constructs was responsive in NB41A3 or PC12 cells either to stimulation by 8-bromo-cAMP or by expression of PKA (Fig. 2 a, b) . In contrast, the CRF promoter was induced from 10-to 40-fold by cotransfection with PKA or 8-bromocAMP treatment. This lack of responsiveness to cAMP was further examined by testing the ability of the ICP0 promoter to bind cAMP-response element binding protein (CREB). CREB was expressed and partially purified as described (Hoeffler et al., 1991) using bacterial expression plasmids from James Hoeffler (University of Colorado). Control extract was made from non-transformed BL21-DE3 bacteria. One µl of CREB or control extract was added to 1 ng of γ-$#P-labelled probes at 4i10% c.p.m. in buffer (Kao et al., 1990) , together with 1 µg of poly(dIndC) in a volume of 10 µl. Complexes were resolved on 5 % acrylamide gels. Double-stranded oligonucleotides for the somatostatin CRE (5h ttggcTGACGTCAgagag 3h) (Montminy et al., 1986) and the ICP0 ICP4\CRE (5h ATTggggAATCGTCActgccgCCC 3h) (Wheatley et al., 1992) were used as probes with a 5h TGACGTCA 3h as a specific competitor. Weak binding of CREB to a radioactive probe containing the putative ICP0 CRE was observed (Fig. 3) . In contrast, the somatostatin CRE gave a CREB-specific signal which was more than 13-fold stronger than ICP0 as judged by densitometry. Specific bands, indicated with arrows, were competed by a 50-fold excess of unlabelled CRE competitor (Fig. 3, lanes 3 and 6) but not by a mutant competitor (data not shown). The complex formed between the ICP0 promoter and control bacterial extract (marked *) was not altered by the wild-type CRE competitor.
Transfection\infection experiments were performed to determine the effect of HSV-1 infection upon transactivation of the ICP0 promoter. The ICP0 null mutant, dlx3.1, was used to examine the role of VP16 and viral components other than ICP0. pSP0 and pGL3-422 were induced 6-to 10-fold by dlx3.1 (Fig. 2 c) , consistent with previous experiments (Bohenzky et al., 1995) . Induction in the absence of this region, however, was minimal, even where upstream sequences were included (pGL3-∆Drd). This transactivation is most likely mediated by the HSV-1 structural protein VP16, since several VP16-responsive TAATGARAT elements are present between k95 and k422.
Studies of a mutant virus, termed ∆Tfi, deleted from k420 to k70, suggested that elements outside of this deletion were sufficient for the transcriptional activation of ICP0 (Davido & Leib, 1996) . Remaining identifiable cis-elements from k70 to k1 were the TATA box (k24), Sp1 (k54) and putative CRE (k64) DNA binding sites. In all three cell types, mutation of the TATA box and the Sp1 DNA binding site led to an average reduction of 3-to 6-fold in constitutive activity relative to pGL3-95 (Fig. 2 d-f ). However, mutation of the putative CRE site had no effect on basal activity.
This analysis has demonstrated that the region from k37 to k95, in the absence of upstream sequences, contains ciselements required for constitutive ICP0 promoter activity. Consistent with this, the region from k74 to k89 is important for constitutive activity (O'Rourke & O'Hare, 1994) . It was shown that a member of the C\EBP family (NF-Y) and an unidentified transcription factor (F2) bind to overlapping sites in this region. The ICP0 promoter sequences from k420 to k70, which include these two cis-elements, are nevertheless dispensable for several growth and reactivation functions (Davido & Leib, 1996) . This deletion, however, was made in a recombinant virus, and therefore sequences upstream of the deletion were present. The presence or absence of upstream sequences is important when assessing the effect of promoter deletions. It is clear from this study, for example, that the activity of the ∆Drd construct (k1 to k420 deleted, k420 to k809 and downstream to j150 are present) is comparable to or higher than that of pGL3-95 (k95 to j150 present). In contrast, the activity of pGL3-37 (k37 to j150 present) is very low. The high activity of pGL3-∆Drd coupled with the observation that the ∆Tfi deletion mutant can efficiently reactivate (Davido & Leib, 1996) suggests the possibility that upstream transcriptional initiation may occur in the absence of VP16. Lack of VP16 stimulation arises either from the absence CAJG of VP16, or the absence of VP16-responsive elements. Ribonuclease protection assays (RPA) suggest upstream transcription initiation can occur for ICP0 from a wild-type viral genome in the absence of VP16 (authors' unpublished data). This putative upstream VP16-independent initiation may upregulate ICP0 expression and reactivation since ∆Tfi reactivates normally, and upstream transcription was not detected for wild-type virus in the presence of cycloheximide by RPA of RNA from infected Vero cells (Davido & Leib, 1996) . Taken together, these observations suggest that different regions of the ICP0 promoter may be involved at specific stages in the virus life-cycle.
The TATA box and Sp1 sites contribute to the constitutive activity of pGL3-95 and relative activities of the mutants were consistent in all cell types, supporting the idea that these sites play roles in basal expression, in addition to the F2 and C\EBP elements (O'Rourke & O'Hare, 1993) . A surprising result was that the ICP0 promoter was unresponsive to cAMP and failed to bind CREB. This contrasts with data showing the ICP0 promoter to be cAMP-inducible (Wheatley et al., 1992) . A number of explanations exist. First, PC12 and NB41A3 cells were used in this study, whereas the previous study used ND7 hybrid cells. Second, appropriate choice of reporter plasmid is important since, for example, PKA can upregulate the ' promoterless ' CAT construct pCATBasic (B. C. Summers & D. A. Leib, unpublished observation). In any case, the acceleration of HSV-1 reactivation by cAMP is unlikely to occur directly through the upregulation of ICP0, but may still occur by indirect or direct transactivation of other viral genes.
